Sleep Apnea and Lung Cancer

• Conditions: Locally Advanced Non Small Cell Lung Cancer

• Registration Number: NCT03741647
• Lead Sponsor: Zagazig University

Brief Summary

cases of locally advanced non small cell lung cancer (diagnosed by PET/CT scan and histopathological confirmation) will be screened for sleep disorders by Epworth sleepiness scale then confirmed by full night polysomnographic study. Blood sample to detect some genetic determinants will be withdrawn

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2018-09-21
• Study First Submitted QC: 2018-11-13
• Study Start: 2018-11-15
• Study First Posted: 2018-11-15
• Status Verified: 2019-12
• Last Update Submitted: 2019-12-25
• Last Update Posted: 2019-12-30
• Primary Completion: 2020-11
• Study Completion: 2021-02

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• patients with locally advanced non small cell lung cancer

Exclusion Criteria

• unable or refuse to perform sleep study
• metastatic cases

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
confirmed Response to treatment	4 weeks from assessment response	CT chest/pelvi-abdomen with contrast (evaluation using RECIST criteria)
assessment Response to treatment	6 weeks from ending therapy	CT chest/pelvi-abdomen with contrast (evaluation using RECIST criteria)

Secondary Outcome Measures

Name	Time	Method
Overall survival	12 months after enrollment	regular patient follow up visit
Progression Free Survival	12 months from confirmed response to treatment	CT chest/pelvi-abdomen with contrast (evaluation using RECIST criteria)

Trial Locations

Locations (1)

Ahmad Abbas; 🇪🇬 Zagazig, Asharqia, Egypt